Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 The efficiency of KD in patients with infantile spasms with prior use of different ASMs

From: A multicenter retrospective cohort study of ketogenic diet therapy in 481 children with infantile spasms

 

No ASMs

1 drug

2 drugs

3 drugs

≥ 4 drugs

n(%)

25 (5.2)

55 (11.4)

158 (32.8)

157 (32.6)

86 (17.9)

1 month(a)

14 (56.0)

26 (47.3)

68 (43.0)

65 (41.4)

33 (38.4)

3 months(a)

12 (48.0)

23 (41.8)

85 (53.8)

89 (56.7)

41 (47.7)

6 months(a)

10 (40.0)

19 (34.5)

65 (41.1)

65 (41.4)

27 (31.4)

12 months(a)

7 (28.0)

12 (21.8)

46 (29.1)

43 (27.4)

14 (16.3)

  1. Note:ASMs anti-seizure medications; a: The response rate in the population with maintenance or reduced ASMs and more than 50% seizure reduction. Data are provided as n (%)
Back to article page

Acta Epileptologica

ISSN: 2524-4434

Contact us